HPP has been involved in studies of HIV-1 immunopathogenesis for over 20 years. The laboratory has undertaken ground-breaking work on the role of human leukocyte antigens in the control of HIV-1 infection and on immune responses associated with partial control of HIV-1 replication.
“Ongoing research excellence to produce humanitarian leaders to help the global community in the fight against HIV/AIDS”
The HPP laboratory is based in the Doris Duke Medical Research Institute building at the University of KwaZulu-Natal’s Nelson R Mandela School of Medicine.
HPP is a research initiative established in 2002 at the University of KwaZulu-Natal in collaboration with Harvard Medical School, USA, and the University of Oxford, UK.
This collaborative programme was initially funded by the Doris Duke Charitable Foundation, but now attracts funding from various other international and local funding agencies.
This laboratory is spread out between the 1st and 2nd floors of the DDMRI. It serves as both a facility for exploratory pathogenesis and translational research into HIV and TB, as well as a sample repository for all HPP’s study samples. The laboratory has capabilities to do viral loads, CD4+ T cell counts, diagnostic, polymerase chain reaction assays, processing of peripheral blood mononuclear cells (PBMCs), advanced flow cytometry, tissue culture, gene expression assays and recombinant DNA technology procedures. The laboratory has access to a Sanger sequencing facility.
Exploratory research capacity includes PBMC isolation, freezing and storage from whole blood, cord blood and leukapheresis samples, genital mucosal sample processing and storage, lymph node excision, processing and storage, DNA isolation, western blotting, amplification, cloning, qualitative and quantitative PCR, sequencing, fluorescent microscopy, luminescence, ELISA, ELISpot, polychromatic flow cytometry and high- and low-resolution genetic testing of select genes. The laboratory has a partnership with Neuberg Global, a large clinical and accredited laboratory, to perform high volume viral load and CD4+ T cell count testing, with overnight turnaround times for these assays.
The HIV Pathogenesis Programme (HPP) is passionate about promoting and developing a love for science and technology in high school learners. On
A year-long double-blind randomised control study at UKZN identified a supplement to help ease mild or moderate COVID-19. The study was undertaken
Nelson Mandela once said: ‘There can be no greater gift than that of giving one’s time and energy to helping others without
UKZN’s HIV Pathogenesis Programme (HPP), a centre of research excellence under the leadership of world-class scientist Professor Thumbi Ndung’u, supervised five young researchers who